adipose tissue mass, accompanied by significantly reduced macrophage infiltrates in the adipose tissues. Furthermore, we found that GABA treatment increased the frequency of splenic Tregs in mice. Apparently, GABA, through its GABAA-Rs on adipocytes, macrophages and T cells, inhibited chronic inflam- mation in adipose tissues, leading to the improvement of glucose tolerance and insulin sensitivity in HFD-fed mice. Given that GABA mainly acts on the peripheral GABA receptors and is safe for human consumption, GABA and other GABAA-R agonists References 1. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11: 98–107. 2. Lazar MA (2005) How obesity causes diabetes: not a tall tale. Science 307: 373–375. 3. Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328: 1676–1685. 4. LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, et al. (2008) Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes 116(Suppl 1): S4–6. 5. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116: 1793–1801. 6. Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367–377. 7. Dyck DJ (2009) Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab 34: 396–402. 8. Shoelson SE, Goldfine AB (2009) Getting away from glucose: fanning the flames of obesity-induced inflammation. Nat Med 15: 373–374. 9. Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93: S64–73. 10. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494–1505. 11. Jiao P, Chen Q, Shah S, Du J, Tao B, et al. (2009) Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor- kappaB and c-Jun NH2-terminal kinase pathways. Diabetes 58: 104–115. 12. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, et al. (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15: 930–939. 13. Nicolaysen A, Gammelsaeter R, Storm-Mathisen J, Gundersen V, Iversen PO (2007) The components required for amino acid neurotransmitter signaling are present in adipose tissues. J Lipid Res 48: 2123–2132. 14. Tian J, Chau C, Hales TG, Kaufman DL (1999) GABA(A) receptors mediate inhibition of T cell responses. J Neuroimmunol 96: 21–28. 15. Reyes-Garcia MG, Hernandez-Hernandez F, Hernandez-Tellez B, Garcia- Tamayo F (2007) GABA (A) receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6/IL-12 production. J Neuroimmunol 188: 64–68. 16. Tian J, Lu Y, Zhang H, Chau CH, Dang HN, et al. (2004) Gamma- aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J Immunol 173: 5298–5304. GABA Treatment for High Fat Diet-Fed Mice may be valuable for the prevention and treatment of obesity and T2DM in the clinic. Author Contributions Conceived and designed the experiments: JT DLK. Performed the experiments: JT JY HND W-SC MPGD CKYY. Analyzed the data: JT HND JY. Wrote the paper: JT DLK. 17. Bhat R, Axtell R, Mitra A, Miranda M, Lock C, et al. (2011) Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A 107: 2580–2585. 18. Tian J, Yong J, Dang H, Kaufman DL (2011) Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis. Autoimmunity 44: 465–470. 19. Tian J, Dang HN, Kaufman DL (2011) Combining antigen-based therapy with GABA treatment synergistically prolongs survival of transplanted ß-cells in diabetic NOD mice. PLoS ONE, (In press). 20. Soltani N, Qiu H, Aleksic M, Glinka Y, Zhao F, et al. (2011) GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc Natl Acad Sci U S A 11692-11697. 21. Bjurstom H, Wang J, Ericsson I, Bengtsson M, Liu Y, et al. (2008) GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol 205: 44–50. 22. Shoelson SE, Herrero L, Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132: 2169–2180. 23. Bluestone JA, Tang Q (2004) Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc Natl Acad Sci U S A 101(Suppl 2): 14622–14626. 24. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772–783. 25. Winer S, Chan Y, Paltser G, Truong D, Tsui H, et al. (2009) Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15: 921–929. 26. Liu J, Divoux A, Sun J, Zhang J, Clement K, et al. (2009) Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 15: 940–945. 27. Qatanani M, Szwergold NR, Greaves DR, Ahima RS, Lazar MA (2009) Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest 119: 531–539. 28. Thorel F, Nepote V, Avril I, Kohno K, Desgraz R, et al. (2010) Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 464: 1149–1154. 29. Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes 60: 391–397. 30. Bansal P, Wang Q (2008) Insulin as a physiological modulator of glucagon secretion. Am J Physiol Endocrinol Metab 295: E751–761. 31. Deiuliis J, Shah Z, Shah N, Needleman B, Mikami D, et al. (2011) Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS One 6: e16376. 32. Lewis RS, Cahalan MD (1995) Potassium and calcium channels in lymphocytes. Annu Rev Immunol 13: 623–653. PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e25338